Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vyant Bio Inc (VYNT)

Vyant Bio Inc (VYNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Vyant Bio to Present at the H.C. Wainwright 23rd Annual Global Conference

VyantBio, Inc. ("Vyant Bio" or the "Company") (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system ("CNS")...

VYNT : 2.28 (+0.88%)
Vyant Bio and Cyclica Announce a Strategic Collaboration to Identify Compounds to Treat CDKL5 Deficiency Disorder

Vyant Bio, Inc., (Nasdaq: VYNT), a leading biotech company discovering new therapeutics for neurological diseases and hard-to-treat cancers, and Cyclica, Inc., the partner of choice for data driven drug...

VYNT : 2.28 (+0.88%)
Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates

Strategic Highlights

VYNT : 2.28 (+0.88%)
Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021

Vyant Bio, Inc. ("Vyant Bio", "Company") (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system (CNS) and...

VYNT : 2.28 (+0.88%)
Vyant Bio to Present at A.G.P.'s Virtual MedTech Summer Conference

Vyant Bio, Inc. ("Vyant Bio", "Company") (Nasdaq: VYNT), an emerging leader in novel drug discovery, is pleased to announce that Jay Roberts, Chief Executive Officer, will present at A.G.P.'s Virtual MedTech...

VYNT : 2.28 (+0.88%)
Vyant Bio Announces Issuance of Key Patent for High-Throughput Optical Assay of Human Mixed Cell Population Spheroids

Vyant Bio, Inc. ("Vyant Bio", the "Company") (Nasdaq: VYNT), an emerging leader in novel drug discovery technologies, announced today that its wholly-owned subsidiary, StemoniX, Inc. ("StemoniX"), was...

VYNT : 2.28 (+0.88%)
Vyant Bio Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 18, 2021 / Vyant Bio Inc (NASDAQ:VYNT) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 18, 2021 at 8:30 AM Eastern...

VYNT : 2.28 (+0.88%)
Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update

Vyant Bio, Inc. (the "Company") (Nasdaq: VYNT), is an innovative biotechnology company focused on partnering with pharmaceutical and other biotechnology companies to identify novel and repurposed therapeutics...

VYNT : 2.28 (+0.88%)
Vyant Bio Announces Investor Conference Call and Webcast for First Quarter 2021

Vyant Bio, Inc. ("Vyant Bio", "Company") (Nasdaq: VYNT), is focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery and development of preclinical...

VYNT : 2.28 (+0.88%)
Vyant Bio to Present at BioNJ's 11th Annual BioPartnering Conference

Vyant Bio, Inc. ("Vyant Bio", "Company") (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery...

VYNT : 2.28 (+0.88%)

Barchart Exclusives

Cryptocurrencies Sink in Reaction to Evergrande Group’s Debt Crisis
Bitcoin (^BTCUSD ) is down more than -2% today at a 1-1/2 month low, adding to Monday’s -8% plunge. Also, Ethereum (^ETHUSD ) is down more than -1% today on top of Monday’s -10% plunge to a 6-week low. Cryptocurrencies have tumbled this week as they succumbed to Monday’s sell-off... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar